ESOFIGHT-LS Capsules is a specialized gastrointestinal formulation designed for the comprehensive management of acid reflux, functional dyspepsia, chronic gastritis, bloating, nausea, and delayed gastric emptying.

Esomeprazole effectively reduces excessive stomach acid production, protecting the gastric mucosa from acid damage. Levosulpiride acts as a prokinetic agent, enhancing gastrointestinal motility, reducing bloating, and relieving nausea associated with acid-related disorders.

This synergistic combination provides:

• Effective acid control

• Enhanced gastric motility

• Reduced reflux episodes

• Relief from abdominal discomfort and fullness

ESOFIGHT-LS is especially beneficial in patients suffering from:

• GERD with motility disorder

• Acid peptic disease

• Stress-induced gastritis

• Chronic dyspepsia

• Functional GI disorders

The combination improves both symptomatic relief and mucosal healing, making it a preferred choice among physicians.

Marketed by Varmed Pharma Pvt Ltd, ESOFIGHT-LS is a premium product in the gastrointestinal PCD Pharma Franchise portfolio, offering excellent profitability and prescription potential across India.